BIOMAT Database Logo BIOMAT Database Logo

Phenobarbitone in rhesus haemolytic disease. 1970

W Walker, and G P McMullin

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D010634 Phenobarbital A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations. Phenemal,Phenobarbitone,Phenylbarbital,Gardenal,Hysteps,Luminal,Phenobarbital Sodium,Phenobarbital, Monosodium Salt,Phenylethylbarbituric Acid,Acid, Phenylethylbarbituric,Monosodium Salt Phenobarbital,Sodium, Phenobarbital
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D004899 Erythroblastosis, Fetal A condition characterized by the abnormal presence of ERYTHROBLASTS in the circulation of the FETUS or NEWBORNS. It is a disorder due to BLOOD GROUP INCOMPATIBILITY, such as the maternal alloimmunization by fetal antigen RH FACTORS leading to HEMOLYSIS of ERYTHROCYTES, hemolytic anemia (ANEMIA, HEMOLYTIC), general edema (HYDROPS FETALIS), and SEVERE JAUNDICE IN NEWBORN. Hemolytic Disease of Newborn,Erythroblastosis Fetalis,Erythroblastoses, Fetal,Erythroblastosis Fetali,Fetal Erythroblastoses,Fetal Erythroblastosis,Fetali, Erythroblastosis,Fetalis, Erythroblastosis,Newborn Hemolytic Disease,Newborn Hemolytic Diseases
D005078 Exchange Transfusion, Whole Blood Repetitive withdrawal of small amounts of blood and replacement with donor blood until a large proportion of the blood volume has been exchanged. Used in treatment of fetal erythroblastosis, hepatic coma, sickle cell anemia, disseminated intravascular coagulation, septicemia, burns, thrombotic thrombopenic purpura, and fulminant malaria.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012204 Rh-Hr Blood-Group System Erythrocyte isoantigens of the Rh (Rhesus) blood group system, the most complex of all human blood groups. The major antigen Rh or D is the most common cause of erythroblastosis fetalis. Rh Factors,Rhesus Blood-Group System,Antigen D, Rh Blood Group,Blood-Group System, Rh-Hr,Blood-Group System, Rhesus,Blood-Group Systems, Rh-Hr,Blood-Group Systems, Rhesus,Factor, Rh,Factors, Rh,Rh Factor,Rh Hr Blood Group System,Rh-Hr Blood-Group Systems,Rhesus Blood Group System,Rhesus Blood-Group Systems,System, Rh-Hr Blood-Group,System, Rhesus Blood-Group,Systems, Rh-Hr Blood-Group,Systems, Rhesus Blood-Group

Related Publications

W Walker, and G P McMullin
Phenobarbitone in rhesus haemolytic disease.
December 1970, Lancet (London, England),
W Walker, and G P McMullin
Phenobarbitone in rhesus haemolytic disease. A controlled trial.
November 1970, Lancet (London, England),
W Walker, and G P McMullin
Rhesus haemolytic disease.
January 1976, Journal of clinical pathology. Supplement (Royal College of Pathologists),
W Walker, and G P McMullin
Rhesus haemolytic disease.
January 1992, Archives of disease in childhood,
W Walker, and G P McMullin
Phototherapy in rhesus haemolytic disease.
April 1972, Lancet (London, England),
W Walker, and G P McMullin
Phenobarbitone treatment in haemolytic jaundice.
November 1969, Lancet (London, England),
W Walker, and G P McMullin
Prevention of Rhesus haemolytic disease.
October 1967, British medical journal,
W Walker, and G P McMullin
Prevention of rhesus haemolytic disease.
May 1967, Lancet (London, England),
W Walker, and G P McMullin
PREVENTION OF RHESUS HAEMOLYTIC DISEASE.
August 1965, Lancet (London, England),
W Walker, and G P McMullin
Phenobarbitone of jaundice in haemolytic patients.
December 1973, British journal of haematology,
Copied contents to your clipboard!